i need to findout the "cash flow statement" from the income statement and balance sheet

1 2018 " M21 1x A B Bio Telemetry, Inc. 2 Balance Sheet 3 As of December 31,2019(in RM000's) 4 2019 5 Assets 6 Cash Cash Equivalents 68,614 7 Receivables 87,476 8 Inventory 5.738 9 Prepaid Assets 6,505 10 Total Current Assets 168,333 11 Net PPE 56,380 12 Goodwill and Other Intangible Assets 430,917 13 Non Current Deferred 12,626 14 Other Non Current Assets 17,464 15 Net Fixed Assets 517,387 16 Total Assets 685,720 17 18 Liabilities and Owner's Equity 19 Payables and Accrued Expense 31,578 20 Pension & Other Post Retirement 13,167 21 Currents Debt and Capital 9,425 22 Current Deferred Liabilities 1,584 23 Total Current Liabilities 55,754 24 Long Term Debt and Capital 191,112 25 Other Non Current Liabilities 71.937 26 Total Liabilities 318,803 27 Common Stock 34 28 Additional Paid in Capital 453,366 29 Retained Earnings -86,014 30 Gain Losses Not Affecting Retained Earnings -469 31 Total Shareholder's Equity 366,917 32 Total Liabilities and Owner's Equity 685,720 33 80,889 52.628 7,323 5,820 146,660 48,377 368,467 19,975 3,322 440,141 586,801 26,268 13,498 6.777 3,080 49,623 193,541 33,152 276,316 33 426,054 -115,858 256 310485 586,801 D E 2017 286,776 114,406 172,370 2016 208,332 78,882 129,450 C27 f A B Bio Telemetry, Inc. 2 Income Statement 3 For the Year Ended December 31, 2019 (in $000's) 4 2019 2018 5 Total Revenue 439,107 399,472 6 (-) Cost of Revenue 164,833 148,986 7 Gross Profit 274,274 250,486 8 (-) Operating Expense 9 Selling General & Administrative Expense 170,757 155,276 10 Research & Development 13,994 11,206 11 (-) Other Income expense 40,313 33,071 12 EBIT 49,210 50,933 13 Interest Expense 9.482 9.429 14 Pretax Income 39,728 41,504 15 Tax Provision 9,884 -370 16 Net Income 29,844 41,874 17 123,919 11,101 42,849 -5,499 4,897 -10,396 6,747 -17,143 85,232 8,355 17,851 18,012 2.242 15,770 -37,667 53,437